Evidence map›Paper›PMID 38861595›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Alfa Herrera, Megan M Packer, Monica Rosas-Lemus, George Minasov, Jiexi Chen, John H Brumell, Karla J F Satchell

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Science advances · 2025
    Article
  4. Biantennary N-glycans As Receptors for MARTX Toxins inbioRxiv : the preprint server for biology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

  • Update of
    2023
5 · Who and what money

Authors and funding

7 authors.

Alfa HerreraDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.ORCID 0000-0002-7081-4208
Megan M PackerDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.ORCID 0009-0004-6747-1269
Monica Rosas-LemusDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
George MinasovDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.ORCID 0000-0001-5460-3462
Jiexi ChenDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
John H BrumellCell Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.ORCID 0000-0002-5802-7789
Karla J F SatchellDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.ORCID 0000-0003-3274-7611

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
TO PROVIDE SCIENTIFIC SUPPORT TO THE CENTERS FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES.75N93022C00035 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SATCHELL, KARLA · 2022 to 2025
$20.7M
TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Vibrio MARTX toxin effectors in signaling and pathogenesisR37AI092825 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Karla J F Satchell · 2022 to 2026
$2.5M
Acquisition of a Thermo Fisher Scientific Q Exactive UHMR mass spectrometerS10OD025194 · OD · NORTHWESTERN UNIVERSITY · PI COMPTON, PHILIP DANIEL · 2018 to 2018
$795k
Small host GTPases: Direct targets of Vibrio vulnificus MARTX toxin effectorsK99AI167819 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HERRERA, ALFA · 2021 to 2022
$197k
Determine host surface interactions of MARTX toxin of foodborne Vibrio vulnificusF31AI172382 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHEN, JIEXI · 2022 to 2024
$131k
HHS | National Institutes of Health (NIH) R01-GM129325HHS | NIH | National Cancer Institute (NCI) CCSG P30 CA060553HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) K99 GM143571HHS | NIH | NIH Office of the Director (OD) S10OD025194Michigan Economic Development Corporation (MEDC) 085P1000817NCI NIH HHS P30 CA060553NIAID NIH HHS 75N93022C00035NIAID NIH HHS F31 AI172382NIAID NIH HHS HHSN272201700060CNIAID NIH HHS K99 AI167819NIAID NIH HHS R37 AI092825NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R01 GM129325NIH HHS S10 OD025194U.S. Department of Energy (DOE) DE-AC02- 06CH11357
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial Toxinsrab GTP-Binding ProteinsVibrio vulnificusADP-Ribosylation FactorsAnimalsFemaleHEK293 CellsHumansMiceMice, Inbred ICRProteolysisVibrio InfectionsADP-Ribosylation FactorsBacterial Toxinsrab GTP-Binding Proteinseffectorhost-pathogen interactionMARTX toxinRab GTPasesVibrio vulnificus

Identifiers

PMID38861595
PMCPMC11194500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.